Vivax malaria: A continuing health threat to the Republic of Korea

被引:60
作者
Park, JW
Klein, TA
Lee, HC
Pacha, LA
Ryu, SH
Yeom, JS
Moon, SH
Kim, TS
Chai, JY
Oh, MD
Choe, KW
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Parasitol, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Clin Res Inst, Seoul 110744, South Korea
[4] Natl Inst Hlth, Dept Virol, Lab Med Zool, Seoul, South Korea
[5] Korean Armed Forces Med Command, Kyonggi Do, South Korea
[6] Eighth US Army Community Hosp, Seoul, South Korea
[7] Prevent Serv Directorate, Med Command 18th, Unit 15281, Seoul, South Korea
[8] Gachon Med Sch, Dept Microbiol, Inchon, South Korea
关键词
D O I
10.4269/ajtmh.2003.69.159
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Vivax malaria reemerged in the Republic of Korea in 1993. Most of the cases occurred among soldiers in the region adjacent to the Demilitarized Zone (DMZ) until 1995. To determine the rate of dispersion of vivax malaria, we evaluated its epidemiologic characteristics. Of 13,903 cases of vivax malaria reported in 2000, 40.1% (5,577) were reported among Republic of Korea military personnel, 26.2% (3,641) among veterans discharged less than two years from the military, and 33.7% (4,685) among civilians. Cases of vivax malaria have rapidly increased annually among counties bordering the DMZ, and have spread to approximately 40 km south of the DMZ. Chemoprophylaxis administered to military personnel may have been responsible for the decreasing number of cases among the Republic of Korea military population. The first mosquito-transmitted cases appeared in early June. Therefore, chemoprophylaxis should be instituted in early April to reduce the number of infected mosquitoes. Extensive intervention is warranted to reduce the spread of vivax malaria in the Republic of Korea.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 25 条
  • [1] Chai In-Ho, 1994, Korean Journal of Parasitology, V32, P195, DOI 10.3347/kjp.1994.32.3.195
  • [2] Chai Jong-Yil, 1999, Korean Journal of Parasitology, V37, P129, DOI 10.3347/kjp.1999.37.3.129
  • [3] EDDLEMAN E E Jr, 1951, U S Armed Forces Med J, V2, P1693
  • [4] Reemergence of Plasmodium vivax malaria in the republic of Korea
    Feighner, BH
    Pak, SII
    Novakoski, WL
    Kelsey, LL
    Strickman, D
    [J]. EMERGING INFECTIOUS DISEASES, 1998, 4 (02) : 295 - 297
  • [5] GARNHAM PCC, 1975, B WORLD HEALTH ORGAN, V52, P21
  • [6] GILLES HM, 1993, BRUCECHWATTS ESSENTI, P127
  • [7] KOREAN VIVAX MALARIA .1. NATURAL HISTORY AND RESPONSE TO CHLOROQUINE
    HANKEY, DD
    JONES, R
    COATNEY, GR
    ALVING, AS
    COKER, WG
    GARRISON, PL
    DONOVAN, WN
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1953, 2 (06) : 958 - 969
  • [8] Hasegawa Y., 1913, J CHOSUN MED SOC, V4, P53
  • [9] KOREAN VIVAX MALARIA .3. CURATIVE EFFECT AND TOXICITY OF PRIMAQUINE IN DOSES FROM 10 TO 30 MG DAILY
    JONES, R
    JACKSON, LS
    DILORENZO, A
    MARX, RL
    LEVY, BL
    KENNY, EC
    GILBERT, M
    JOHNSTON, MN
    ALVING, AS
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1953, 2 (06) : 977 - 982
  • [10] Kho Weon-Gyu, 1999, Korean Journal of Parasitology, V37, P265, DOI 10.3347/kjp.1999.37.4.265